Enterome to attend upcoming conferences

Paris, France – October 4, 2021

ENTEROME SA, a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases, today announces that Pierre Belichard, CEO, will attend and take part in 1-on-1 meetings with institutional investors at the following conferences:

  • BMO fall Life Sciences Private Company Showcase: October 14
  • Jefferies Annual IBD Next Generation Therapeutics Summit: October 19
  • Jefferies Global Healthcare Conference: November 16 -18

Download the press release (.pdf format)

 

Enterome France

Headquarters
94/96 avenue Ledru-Rollin 75011 Paris – France
Tel: +33 (0)1 75 77 27 85
Lab facilities
Biocluster Genopole
5 rue Henri Desbruères – 91030 Evry Cedex